Sacco System is the international biotechnological company dedicated to the food, nutraceutical, and pharmaceutical industries, based on tradition, expertise, research, and innovation which sells and distributes its ingredients in more than 110 countries around the world. Today Sacco System is a worldwide company, that maintains a family spirit where people and human relations are at the center. Collaborators, suppliers, and clients are part of a large family based on care and respect.
Sacco System wants to contribute to improving the well-being of humans, animals and plants, as as evidenced by the corporate mission: “Supporting food culture and life”.
The high quality of the products, the continuous and constant innovation process, the capacity to work on the sides of clients, knowledge sharing, the training of employees and an attention for the environment, are the pillars of the organization Sacco System.
Sacco System comprises more than 460 collaborators and a turnover of more than 150 million euros (2022). The production facilities are in Cadorago (Italy), Zelo Buon Persico (Italy), Skurup (Sweden) and Franksville (Wisconsin); there are branches in Singapore, France, Japan and a pilot site dedicated to biotherapeutics in Australia.
CSL FRANCE, founded in 1994, is the French branch of SACCO SYSTEM and has now changed its name to SACCO SYSTEM FRANCE. No changes will occur in the quality of the service and the products offered by SACCO SYSTEM FRANCE, which has been present for more than 30 years on the French market, in Benelux, and in French Africa. It offers a comprehensive portfolio of frozen and lyophilized cultures for acidification, aromatization, refinement, bio-protection, surface treatment, gasogenesis, coagulants, enzymes, and probiotics. The company is committed to providing a high level of technical assistance service and achieving commercial excellence dedicated to its clients.
“I am extremely proud of the journey started in 1994 by CSL France, which saw a name change to become Sacco System France, today, as in the past, always standing alongside French dairies, offering the best biotechnological solutions and technical consultancy services. Sacco System France is now an essential part of the Sacco System group; over time, the Company has grown thanks to the commitment and competence of the People who have worked and collaborated at CSL France. Looking ahead, I see numerous new opportunities, also arising from the markets of African countries. By persistently focusing on excellence in technical assistance and customer orientation, market results will only improve day by day. Sincere thanks go to People who contributed to this success story” (Martino Verga – Ownership).
“The transition from CSL France to SACCO SYSTEM FRANCE is a significant moment, confirming our commitment to further enhance the tradition and unique characteristics of the leading dairy sector in France in a more modern and innovative manner” (Adrian Gauna – Sacco System Regional Sales Director).
Latest News
An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.
The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy
The Group is accelerating its South American growth strategy through a twofold transaction: the acquisition of a Uruguayan company and the full absorption of its Brazilian subsidiary. The Group is
Milk is the most precious resource in dairy production. High-quality dairy products start with high-quality milk—and in today’s rapidly evolving dairy landscape, protecting that quality has never been more critical.
“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been
GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a
Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1
We are proud to present the fifth edition of our Sustainability Report, an opportunity to reflect on the milestones achieved and the challenges ahead…
Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland…
At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici…
List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement…
Sacco System is the international biotechnological company dedicated to the food, nutraceutical, and pharmaceutical industries…